NutriBand Inc
For the period ended Oct 31, 2024. Filed Dec 4, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 31, 2024 · Filed Dec 4, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended October 31, 2024
OR
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File Number 001-40854
NUTRIBAND INC.
(Exact name of registrant as specified in its charter)
| NEVADA | 81-1118176 |
|---|---|
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| 121 South Orange Ave., Suite 1500, Orlando, FL | 32801 |
|---|---|
| (Address of Principal Executive Offices) | (Zip Code) |
(407) 377-6695
(Registrant’s Telephone Number, Including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common Stock | NTRB | The Nasdaq Stock Market LLC |
| Warrants | NTRBW | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐No ☒
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
|---|---|---|---|
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No☒
The number of shares outstanding of the issuer’s common stock, par value $0.001 per share, was 11,106,185 shares as of December 2, 2024
NUTRIBAND INC.
INDEX
| Page No. | ||
|---|---|---|
| Part I: Financial Information | 1 | |
| Item 1 | Financial Statements | 1 |
| Condensed Consolidated Balance Sheets as of October 31, 2024 (unaudited) and January 31, 2024. | 2 | |
| Condensed Consolidated Statements of Operations for the three and nine months ended October 31, 2024 and 2023(unaudited), | 3 | |
| Consolidated Statements of Stockholders’ Equity for the nine months ended October 31, 2024, and 2023 (unaudited) | 4 | |
| Condensed Consolidated Statements of Cash Flows for the three and nine months ended October 31, 2024, and 2023 (unaudited) | 6 | |
| Notes to Unaudited Condensed Consolidated Financial Statements | 7 | |
| Item 2 | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 25 |
| Item 3 | Quantitative and Qualitative Disclosures about Market Risk | 34 |
| Item 4 | Controls and Procedures | 34 |
| Part II: Other Information | 35 | |
| Item 1. | Legal Proceedings | 35 |
| Item 1A | Risk Factors | 35 |
| Item 6 | Exhibits | 39 |
i
NUTRIBAND INC.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.